The Architects' Journal2d
First images revealed of plans to convert GlaxoSmithKline HQ into homes
The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...
pharmaphorum19d
GSK first to sign ‘open research’ deal with London’s Crick Institute
GlaxoSmithKline (GSK) is to collaborate with the Francis Crick Institute, a new powerhouse of academic- and charity-funded biomedical research based in London. The new partnership is expected to ...
GSK abandons diversity targets following Trump pressure
British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...
ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...
Charity promoting health and care volunteering in Bradford wins top UK health award
An ambitious London-based charity that has grown its impact across England has scooped one of this year’s GSK IMPACT Awards, ...
Yahoo Finance8d
GSK's (LON:GSK) Conservative Accounting Might Explain Soft Earnings
The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...
Charity working with Bradford NHS wins GSK Impact Award
A charity that is currently working at Bradford District Care NHS Foundation Trust, has won a prestigious award for its work in ...
Medical Dialogues10d
USFDA accepts GSK depemokimab applications for review for asthma, chronic rhinosinusitis
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License ...
FDA to review GSK's depemokimab
Pharmaceutical giant GSK said on Monday that the US Food and Drug Administration has agreed to review its Biologics License ...